We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $113.5 · 16 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
HealthEquity, Inc. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
HealthEquity, Inc. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next Yahoo Finance
HealthEquity (HQY) Net Margin Jump To 17.3% Tests Bullish Profitability Narrative - simplywall.st
HealthEquity (HQY) Net Margin Jump To 17.3% Tests Bullish Profitability Narrative simplywall.st
Analysts’ Top Healthcare Picks: Healthequity (HQY), Teladoc (TDOC) - The Globe and Mail
Analysts’ Top Healthcare Picks: Healthequity (HQY), Teladoc (TDOC) The Globe and Mail
HealthEquity, Inc. Stock 12‑Month Price Target Raised to $114.56, Implies 27% Upside - TradingView
HealthEquity, Inc. Stock 12‑Month Price Target Raised to $114.56, Implies 27% Upside TradingView
How Investors May Respond To HealthEquity (HQY) Upgraded Outlook, AI Efficiencies and Larger Buyback Plan - simplywall.st
How Investors May Respond To HealthEquity (HQY) Upgraded Outlook, AI Efficiencies and Larger Buyback Plan simplywall.st
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 28. | After market close (AMC) | $1.19 | — | — | $347.99M | — | Scheduled |
| FY2027 Q1 | 2025. 04. 30. | Time TBD | — | $0.61 | — | — | $330.84M | Reported |
| FY2026 Q3 | 2024. 10. 31. | Time TBD | — | $0.79 | — | — | $887.96M | Reported |
| FY2026 Q2 | 2024. 07. 31. | Time TBD | — | $0.73 | — | — | $587.53M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 30. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 05. 23. | Barrington Research | — | Maintain | Outperform → Outperform | — | Barrington Research: Outperform |
| 2026. 04. 09. | BMO Capital | — | Upgrade | Market Perform → Outperform | — | BMO Capital: Market Perform → Outperform |
| 2026. 03. 20. | Deutsche Bank | — | Maintain | Buy → Buy | — | Deutsche Bank: Buy |
| 2026. 03. 19. | Barrington Research | — | Maintain | Outperform → Outperform | — | Barrington Research: Outperform |
| 2026. 03. 19. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
As of FY2027Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 182,017 | $16.67B | 0.03% | — | New position |